NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 89 filers reported holding NGM BIOPHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 2.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $294,318 | -58.2% | 275,064 | +1.2% | 0.00% | – |
| Q2 2023 | $703,672 | -47.0% | 271,688 | -16.4% | 0.00% | – |
| Q1 2023 | $1,326,506 | -19.4% | 325,124 | -0.9% | 0.00% | -100.0% |
| Q4 2022 | $1,646,429 | -60.0% | 327,974 | +4.3% | 0.00% | 0.0% |
| Q3 2022 | $4,115,000 | +3.0% | 314,559 | +0.9% | 0.00% | 0.0% |
| Q2 2022 | $3,996,000 | -12.5% | 311,675 | +4.0% | 0.00% | 0.0% |
| Q1 2022 | $4,569,000 | -8.0% | 299,547 | +6.8% | 0.00% | 0.0% |
| Q4 2021 | $4,968,000 | -14.1% | 280,468 | +1.9% | 0.00% | -50.0% |
| Q3 2021 | $5,786,000 | +61.1% | 275,246 | +51.1% | 0.00% | +100.0% |
| Q2 2021 | $3,592,000 | -24.6% | 182,110 | +11.1% | 0.00% | -50.0% |
| Q1 2021 | $4,767,000 | +19.7% | 163,973 | +24.7% | 0.00% | 0.0% |
| Q4 2020 | $3,984,000 | +93.1% | 131,499 | +1.4% | 0.00% | +100.0% |
| Q3 2020 | $2,063,000 | +27.3% | 129,660 | +58.0% | 0.00% | 0.0% |
| Q2 2020 | $1,620,000 | +62.7% | 82,061 | +1.7% | 0.00% | 0.0% |
| Q1 2020 | $996,000 | -31.9% | 80,707 | +2.1% | 0.00% | 0.0% |
| Q4 2019 | $1,462,000 | +160.6% | 79,052 | +95.4% | 0.00% | – |
| Q3 2019 | $561,000 | -0.5% | 40,461 | +5.1% | 0.00% | – |
| Q2 2019 | $564,000 | – | 38,487 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Column Group LLC | 15,396,116 | $303,611,000 | 42.97% |
| Ponoi II Management, LLC | 1,298,908 | $25,614,000 | 20.76% |
| Ponoi Management, LLC | 1,298,908 | $25,614,000 | 14.23% |
| Euclidean Capital LLC | 1,493,349 | $29,449,000 | 9.56% |
| RHO CAPITAL PARTNERS INC | 3,766,666 | $74,279,000 | 6.80% |
| Aquilo Capital Management, LLC | 1,194,237 | $23,550,000 | 6.12% |
| Greenspring Associates, LLC | 1,573,357 | $31,027,000 | 2.10% |
| Octagon Capital Advisors LP | 200,000 | $3,944,000 | 0.82% |
| Redmile Group, LLC | 2,792,448 | $55,067,000 | 0.82% |
| BVF INC/IL | 955,000 | $18,833,000 | 0.71% |